The Evidence on Ozempic to Treat Addiction
GLP-1 drugs like Ozempic, originally developed for diabetes, are showing unexpected potential in reducing addictive behaviors by modulating the brain’s reward system, though concerns remain about emotional blunting and access disparities.
THESIS
While GLP-1 receptor agonists such a
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Dhruv Kaul
solo on The New Yorker Radio Hour
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Products & Tools
Topics
Listen to This Episode
More from The New Yorker Radio Hour
“Fat Swim” and Literature’s Fatphobia Problem
Social Media Goes to Court
How Betting Took Over Sports
Sarah Longwell, a Former Republican, on “How to Eat an Elephant”
How an Estimated Seven Hundred Thousand People Have Died from DOGE’s U.S.A.I.D. Cuts
Erin Brockovich Takes on Data Centers
Related episodes
From other shows on similar topics.
Rethinking addiction in the age of Ozempic
TED Radio Hour
What we got wrong about GLP-1s
Search Engine
People are running their own experiments with GLP-1s — with stunning results
Apple News Today
Skinny and sad on GLP-1s
Today, Explained
Ozempic for All?
The Daily
How Big Food Is Navigating the GLP-1 Era
The Journal.
Get summaries like this every morning.
Free AI-powered recaps of The New Yorker Radio Hour and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.